Saving Lives One Strip at a Time: MabLab Brings Multi-Drug Testing to the Forefront

For anyone who loves to party or hit the dance floor, the risk of accidentally ingesting adulterated drugs is a very real concern. MabLab, a startup taking the stage at TechCrunch Disrupt 2024, is stepping up to address this serious issue with a groundbreaking new solution: a testing strip that can detect five common and dangerous drug additives in just minutes.

Co-founders Vienna Sparks and Skye Lam were inspired to create MabLab after tragically losing a friend to an overdose during their college years. This heartbreaking experience, one that many people understand all too well, fueled their mission to develop a better way to protect individuals from the dangers of unknowingly consuming laced substances.

Beyond the One-Drug Test: MabLab’s Five-in-One Solution

Testing strips are already a familiar sight at various venues and health centers, with millions shipped annually. These strips typically detect a single substance, most commonly fentanyl. While these single-drug tests are a valuable tool, MabLab aims to achieve a significant advancement. Their innovative testing strip can simultaneously detect five common lacing chemicals: fentanyl, methamphetamine, benzodiazepine, xylazine, and methadone.

“We have an opportunity to replace that with a better version,” said Lam. “One that detects five common lacing chemicals simultaneously.”

The company’s innovative approach involves a “mix of physical and chemical” elements: “There’s a zone specifically designed for each agent, and we’re using novel treatments and materials on the strip to allow capillary action to occur without incurring cross-reactivity,” explained Sparks. In simpler terms, this means the different zones on the strip are carefully designed to prevent interference between the chemicals, ensuring accurate and unambiguous results.

More Than Just Testing: Shifting the Culture Around Drug Use

MabLab envisions a world where drug testing is normalized, much like condom distribution. Their goal is to empower individuals to make informed decisions about their safety by providing a readily accessible and reliable means of testing the purity of substances. “We’re seeing a cultural change: people on campuses and at music festivals encouraging friends to test,” Sparks said. “People are aware there’s a threat, and a way to be safer that isn’t abstinence — an approach that is, for drugs or other practices, seldom adopted by teens and college kids.

“It’s very similar to condom distribution,” said Lam; a proven way to mitigate risk is to give people the opportunity to do things safely and then get out of the way.”

MabLab believes their testing strips can be valuable tools for various organizations, including university health systems, harm reduction centers, homeless shelters, needle exchanges, and even emergency medical services (EMTs) responding to overdoses.

Building a Safer Future: MabLab’s Journey Forward

Sparks noted that they are actively working toward establishing partnerships with institutions that already have established distribution channels. “Looking toward the future, the biggest thing is getting those [letters of intent] that already have distribution channels in place,” said Sparks.

The company is also prioritizing rapid scaling of its production, leveraging the expansion of medical testing supply chains to ensure a continuous supply of their life-saving technology.

MabLab has already started assembling its team and is poised to ship its first batches of testing strips. If their innovative product meets the market with the success they anticipate, MabLab has the potential to revolutionize the way we approach drug safety and ultimately save countless lives around the word.

**Ready to help make a difference? Get involved with MabLab and support their mission of creating a safer world, one test stripe at a time.**